Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BigBearai Holdings Inc (BBAI) vs Hims and Hers Health Inc (HIMS) Price & Performance

BigBearai Holdings IncTrade
Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

BigBearai Holdings Inc vs Hims and Hers Health Inc — how do they compare? BigBearai Holdings Inc trades at $3.32 (market cap $1.55B), while Hims and Hers Health Inc trades at $30.69 (market cap $7.35B). The key difference: Hims and Hers Health Inc is far larger — about 4.7× BigBearai Holdings Inc's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, BigBearai Holdings Inc nearer its low. Which is the better fit depends on your goals.

BBAIHIMS
Market Cap
$1.55B$7.35B
Sector
TechnologyHealth
52-Week High
$8.91$62.76
52-Week Low
$2.61$14.52
Enterprise Value
$1.25B$7.73B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BigBearai Holdings Inc

BBAI trades at $3.27, up 8.64% with a bullish technical signal despite negative profitability metrics. The company reported Q2 2026 revenue growth of 13% and beat EPS estimates, though it remains unprofitable with a -65.2% net income margin. Recent news highlights defense contract execution and generative AI platform expansion for government clients.

The outlook remains challenging due to persistent losses and negative cash flow from operations, though analyst consensus leans neutral with 75% hold ratings. Key risks include execution on government contracts and achieving profitability, while technical indicators suggest near-term bullish momentum.

Hims and Hers Health Inc

Hims & Hers Health stock trades at $31.59, up 6.51% today, showing strong momentum. The technical outlook is bullish, with the price above key moving averages and support at $30. Fundamentally, revenue growth is robust at 40% year-over-year in Q2 2026 (MarketBeat, 2026-08-10), but profitability remains challenged with a net loss margin of -0.56% in 2026. The company raised its annual revenue forecast to $3.1–3.3 billion (WSJ, 2026-08-10), reflecting confidence in subscriber growth and expansion into weight-loss treatments.

The investment outlook is mixed: strong revenue growth and bullish analyst targets near $35.60 offer upside, but high valuation ratios (P/E of 57.14) and recent earnings misses heighten risk. Key risks include margin pressure from GLP-1 investments and ongoing legal investigations. Wall Street sentiment is cautious, with 65% hold ratings, suggesting patience for profitability improvements.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BigBearai Holdings Inc

BigBearai Holdings Inc is a specialized provider of AI-driven decision intelligence solutions, primarily serving the U.S. defense, intelligence, and national security communities. It operationalizes complex data into actionable insights through its core modules—Observe, Orient, and Dominate—to support mission-critical operations and logistics.

Read more on BBAI

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS